To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Cofact is a combination of blood clotting factors II, VII, IX and X. It consists of a protein fraction prepared from fresh-frozen human blood plasma. It is used in patients receiving oral anticoagulation therapy for the treatment and prevention of thrombosis when bleeding occurs (e.g. in the brain) requiring rapid action to accelerate coagulation. It is also used when such a patient must undergo an emergency operation treatment. Other indications include a deficiency of one of the included clotting factors, either congenital or due to liver disease. It is available as a powder and solvent for solution for injection.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Cofact". A list of authors is available in Wikipedia.|